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Abstract
Squalene is present in high concentration in the liver of certain sharks and in small
concentrations in olive oil. Previous studies showed that its administration decreases
hepatic steatosis in male Apoe-knockout mice, but these changes might be complex.
Transcriptomics,  using DNA microarrays,  and proteomics from mitochondrial  and
microsomal fractions, analyzed by 2D-DIGE and mass spectrometry, were used in these
mice  that  received  1  g/kg/day  squalene  for  10  weeks.  Squalene  administration
significantly  modified the expression of  genes such as  lipin 1  (Lpin1)  and thyroid
hormone  responsive  (Thrsp).  Changes  in  methionine  adenosyltransferase  1  alpha
(Mat1α),  short-chain  specific  acyl-CoA  dehydrogenase  (Acads),  and  thioredoxin
domain–containing protein 5 (Txndc5) expressions were consistent with their protein
levels.  Their  mRNA levels  were associated with hepatic  fat  content.  These results
suggest that squalene action involves changes in hepatic gene expression associated
with  its  anti-steatotic  properties.  This  approach  shows  new  connections  between
nutrition and gene expression since Txndc5, a gene with unknown biological function,
was  upregulated by squalene  administration.  Overall,  this  nutrigenomic  approach
illustrates the effects of squalene and provides further support to the idea that not all
monounsaturated fatty acid–containing oils behave similarly. Therefore, selection of
cultivars producing olive oils enriched in this compound will be a plus.
Keywords: Apolipoprotein E–deficient mice, Virgin olive oil, Squalene, Lpin1 , Thrsp ,
Mat1a , Acads , Txndc5
1. Introduction
The “Seven Countries” Study evidenced that cardiovascular mortality was the lowest in
Mediterranean  countries  compared  to  other  regions  participating  in  the  study  [1].  The
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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and reproduction in any medium, provided the original work is properly cited.
Mediterranean dietary pattern is not only associated with lower cardiovascular mortality but
also with total mortality [2]. Dietary interventions using Mediterranean diets have resulted in
favorable outcomes either in primary [3] and secondary prevention by reducing the number
of  coronary  events  and  death  toll  [4].  All  these  evidences  have  provided  the  scientific
background to propose the Mediterranean Diet as an intangible cultural heritage of humani‐
ty (http://www.unesco.org/culture/ich/es/RL/00394).
In traditional Mediterranean diet, the main source of fat was olive oil [5]. Virgin olive oil, an
example of oil extracted by physical means, is a functional food since it contains several
components that may contribute to its overall biological properties. Known for its high levels
of triacylglycerols containing monounsaturated fatty acids, it is a good source of phytochem‐
icals such as squalene [6], phenolic compounds [7, 8], terpenes, phytosterols, and alpha-
tocopherol [9, 10]. The content of squalene in virgin olive oil shows a great variability, from
1.5 to 9.6 g/kg [11], and may vary according to grove varieties [12]. In spite of this variation,
squalene represents the second most abundant component of virgin olive oils and the highest
in commonly consumed vegetable oils [13]. In some refinement processes, the loss of squalene
may reach a 20 % [6]. However, this molecule remains stable in virgin olive oil heated at 180
°C for 36 h [14]. Its thermal stability makes squalene suitable to ensure its intake when
consumed both in cooked and raw food. In vitro, it is a highly effective oxygen-scavenging
agent, and it has been shown to be chemopreventive against several tumors [a detailed review
of its described properties is found in Ref. [13]].
The average intake of squalene is 30 mg/day in the United States. However, when consumption
of olive oil is high, the intake of squalene can reach from 200 to 400 mg/day, as observed in
Mediterranean countries [15], or even can amount up to 1 g daily [16]. Despite the fact that
plasma squalene levels come from endogenous biosynthesis in addition to dietary sources, its
concentration is higher in those human populations consuming virgin olive oil or shark liver
[17]. Its stability and bioavailability make squalene an attractive compound to characterize its
biological properties.
2. The liver: an organ sensitive to diet nutrients
The liver secretes phospholipids, cholesterol, and triacylglycerols into plasma as lipoprotein
complexes, which allow the transport of those lipids into the aqueous medium of blood.
Apolipoproteins such as APOB100, APOA1, APOA2, and APOE are the main protein constit‐
uents of lipoproteins. Furthermore, this organ also secretes the enzymes (hepatic lipase,
lecithin-cholesterol acyltransferase, and phospholipid transfer protein) involved in the plasma
transformation of lipoproteins [18].
Apoe-deficient mice lack APOE, and as consequence, the elimination of lipoproteins from blood
is impaired. Due to this fact, lipoproteins accumulate into vessel walls contributing to the
development of spontaneous atherosclerosis [19]. When fed with high-fat diets, these mice
induced changes in plasma apolipoproteins [20], as a result of hepatic apolipoprotein gene
expression variations [21]. This adaptive response of the liver as an effect of different olive oil
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intakes represents an ideal model to explore changes in diet composition. Using Apoe-deficient
mice as a model of spontaneous atherosclerosis and baseline steatosis, our group showed that
squalene administration decreased atherosclerotic lesion [22] and exhibited an association
between hepatic fat content and atherosclerotic progression. In this study, squalene accumu‐
lated in the liver and was able to decrease the storage of hepatic triacylglycerols. We concluded
that squalene was transported to the liver in an apolipoprotein E–independent way, and its
mechanisms of action were complex. To address this complexity, high-throughput approaches
of transcriptomics and proteomics have been employed to further characterize squalene action.
The livers of Apoe-deficient mice fed with chow diets or the same diets supplemented with
squalene were analyzed. The chapter will review our experience dealing with squalene and
the use of omic technologies to explore its effects.
3. Methodological workflow
Two-month old, male, homozygous Apoe-deficient mice with C57BL/6J × Ola129 genetic
background were used. Two study groups of equal plasma cholesterol were established: (a)
one received chow diet, and its beverage contained 1 % (v/v) of glycerol solution (n = 8) and
(b) the other received the same chow diet, but its drinking solution was supplemented with
squalene to provide a 1 g/kg/day dose (n = 9). For 10 weeks, mice were fed with experimental
diets, which were well tolerated since there was no incidence on survival, physical appearance,
and solid and liquid intakes, as described previously [22]. After this time, animals were
sacrificed and the liver removed. One aliquot stored in neutral formaldehyde was used to
evaluate the extent of lipid droplets, expressed as the percentage of total liver section, and the
remaining, frozen in liquid nitrogen, was used to extract its total RNA and to isolate subcellular
fractions.
The changes in expression of 22,690 transcripts represented on the Affymetrix GeneChip
Murine Genome MOE430A array were analyzed to find out the effect of squalene. In order to
do that, pooled liver samples of eight mice on the chow diet were compared with those
receiving the compound, as depicted in Figure 1.
The huge amount of information provided by microarrays requires further processing in order
to get a meaningful and manageable data to work with, such as selecting only the genes with
the highest expression changes or those involved in a certain metabolic pathway [23]. In the
present work, the first approach has been adopted, and only those genes whose expression
was strongly modified (signal log2 ratio ≥ 1.5 or ≤1.5) were considered highly responders to
the intake of squalene. Gene expression was later confirmed by quantitative reverse transcrip‐
tase-polymerase chain reaction (RT-qPCR) to reinforce the validity of results.
For the preparation of mitochondrial and microsomal fractions, livers were homogenized in
PBS (4 ml/g of tissue) with protease inhibitor cocktail tablets (Roche). Tissue debris was
removed by centrifugation at 200 × g for 10 min at 4 °C. The homogenate was spun down at
1,000 × g for 15 min. The supernatant-containing mitochondria were centrifuged at full speed,
13,000 × g for 2 min. The mitochondrial pellets were then washed twice, pelleted, resuspended
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in PBS, and spun for 1 min. Microsomal fractions resulted from centrifugation of the post
mitochondrial supernatant at 105,000 × g for 90 min. These pellets were washed twice, spun
at the same speed, and finally resuspended in 0.5 ml of PBS [24, 25].
Figure 1. Graphical representation of the used approach. The process encompasses RNA preparation, microarray proc‐
essing to select expression changes, and confirmation by quantitative reverse transcriptase-polymerase chain reaction
(RT-qPCR) of individual samples.
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Differential protein expression was analyzed by DIGE analysis. Spots whose densities
significantly differed between treatments were excised from the preparative gel and subjected
to tryptic digestion and identification by mass spectrometry, as described [24, 25].
4. Squalene-induced global changes in hepatic gene expression
Affymetrix software identified 11,528 transcripts as expressed in the livers of chow-fed mice
and 11,187 in those of squalene-fed animals. According to the Mann-Whitney ranking feature
of the Affymetrix software (P < 0.01), squalene administration increased and reduced the
expression of 413 and 428 sequences, respectively. The original data were deposited in the GEO
repository (accession number GSE36932).
Biological process  GenBank  Name  Gene
symbol 
Chow Squalene Signal
log2ratio 
Upregulated genes
Cell signaling NM_011267 Regulator of G-protein signaling
16
Rgs16 102 543 2.5
Nuclear protein NM_009381 Thyroid hormone-responsive
SPOT14 homolog (Rattus)
Thrsp 238 760 1.7
Lipid metabolism NM_172950 Lipin1 Lpin1 423 1675 1.6
Transcription 
factor
NM_011575 Trefoil factor 3 intestinal Tff3 200 503 1.5
Transcription
factor 
NM_016974 D site albumin promoter
binding protein
Dbp 589 1547 1.5
Downregulated genes
Cell cycle NM_008059 G0/G1 switch gene 2 G0s2 3012 487 −2.5
Transcription factor NM_007489 Aryl hydrocarbon receptor
nuclear translocator-like
Arntl 66 11 −2.3
Cell signaling NM_019840 Phosphodiesterase 4B Pde4b 82 24 −1.8
Immunity NM_010378 Histocompatibility 2, class II
antigen A, alpha
H2-Aa 944 583 −1.5
Immunity NM_010382 Histocompatibility 2, class II
antigen E beta
H2-Eb1 357 140 −1.5
Data represent intensity of signal for each condition with the Affymetrix chip.
Table 1. Hepatic genes differentially regulated by the administration of squalene at the level of signal log2 ratio ≥ 1.5 or
≤ 1.5 in male Apoe-deficient mice.
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To select the most relevant, only differentially regulated genes with a signal log2 ratio ≥ 1.5 (for
those genes upregulated) or ≤ 1.5 (for those repressed) were taken into account. Table 1 lists
the genes whose mRNAs reflected these changes. Five genes showing increased expression as
a response to the administration of squalene. Two of these genes coded for transcription factors
(Dbp and Tff3) and three for proteins with miscellaneous functions (one of them was involved
in lipid metabolism [Lpin1], the second was a signaling molecule [Rgs16], and the third was a
nuclear protein [Thrsp]). Five genes met the criterion of showing a reduced expression as a
response to the administration of squalene (Table 1). Of these, two were involved in immunity
(H2-Aa and H2-Eb1), one was a transcription factor (Arntl), one was involved in cell cycle
(G0s2), and finally one coded for an enzyme involved in cellular signaling (Pde-4b).
Chow (n = 8) Squalene (n = 9) Fold change SL2R
Upregulated genes
Rgs16 0.91 ± 0.16 11.64 ± 1.5** 12.8 3.7
Thrsp 0.92 ± 0.13 4.00 ± 0.65** 4.3 2.1
Lpin1 0.96 ± 0.19 9.77 ± 2.00** 10.2 3.3
Tff3 0.85 ± 0.11 1.26 ± 0.29 1.6 0.6
Dbp 0.92 ± 0.20 3.76 ± 0.72** 4.08 2.0
Downregulated genes
G0s2 0.56 ± 0.19 0.13 ± 0.02* 0.2 −2.3
Arntl 1.19 ± 0.25 0.46 ± 0.07** 0.4 −1.3
Pde4b 1.11 ± 0.17 1.22 ± 0.27 1.1 0.1
H2-Aa 0.94 ± 0.18 0.92 ± 0.18 1.0 0.0
H2-Eb1 1.01 ± 0.16 0.75 ± 0.23 0.7 −0.5
Data (means ± SEM) represent arbitrary units normalized to the Cyclophilin B expression for each condition with the
RT-qPCR. Statistical analysis was carried out by the Mann-Whitney U test. **P ≤ 0.01 vs chow, *P ≥ 0.05 vs chow.
Table 2. Effect of squalene on the hepatic gene expression in male Apoe-deficient mice.
To validate the results obtained with the microarray, the expressions of the above genes—
Arntl, Dbp, G0s2, H2-Aa, H2-Eb1, Lpin1, Pde-4b, Rgs16, Tff3, and Thrsp—that were up- or
downregulated were individually analyzed by specific RT-qPCR assays. Cyclophilin B was the
reference gene used to normalize the results (Table 2).
Four out of the five upregulated genes included in the validation analysis—Rgs16, Thrsp,
Lpin1, and Dbp—were confirmed to be significantly increased in their expressions by the
squalene administration. Two of the five downregulated genes selected—G0s2 and Arntl—
were significantly decreased in male mice receiving squalene. Good agreement between these
procedures was obtained (r = 0.94, P < 0.007), and all samples except the two were correctly
classified, although the magnitude of the response differed between both methods. These
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results indicate that pooled samples can be successfully used to provide an initial screening of
gene expression, with the economic and timesaving benefits and with the limitation of no
information on biological variability.
To further explore the significance of these changes, correlation analyses between hepatic fat
and gene expressions were studied. Two genes, Lpin1 and Thrsp, showed significant inverse
associations (Figure 2).
Figure 2. Association analysis among liver fat content and hepatic mRNA levels in male ApoE-deficient mice. Correla‐
tions were calculated according to Spearman’s test, and values corresponding to all experimental groups have been
included. Squares and triangles correspond to chow and squalene groups, respectively.
Squalene modulated these genes and could modulate hepatic lipid metabolism. In fact, LPIN1
(LIPIN1) plays a dual function in lipid metabolism by (1) catalysis of the conversion of
phosphatidate to diacylglycerol, required for triacylglycerol and phospholipid biosynthesis,
and (2) by acting as a transcriptional regulator. Through its 3-sn-phosphatidate phosphatase
activity, this protein favors triacylglycerol biosynthesis [26]. Conversely, acting as a transcrip‐
tional regulator, it suppresses the lipogenic program [27]. Accordingly, a hypothetical increase
in nuclear LPIN1 protein levels induced by the action of squalene may explain the strong
negative association with hepatic fat content (Figure 1). THRSP is also a nuclear protein that
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participates in the regulation of lipid synthesis by modulating the levels of lipogenic enzymes
such as ATP citrate lyase, fatty acid synthase, and malic enzyme [28]. However, Thrsp-deficient
mice showed enhanced lipogenesis, which led to the finding of its paralog, called S14R [29].
THRSP and S14R might have an overlapping role in this metabolism [30]. Interestingly, Lipin1
and Thrsp expressions showed a strong positive association (r = 0.84, P < 0.001], suggesting that
they both play a role in lipid metabolism and are influenced by squalene administration.
5. Squalene-induced changes in mitochondrial proteins
The mitochondrial proteome analysis unveiled caused induction of methionine adenosyl‐
transferase 1 alpha and decreased short-chain specific acyl-CoA dehydrogenase levels [24].
Both changes were associated with lipid droplet area (r = –0.661 and 0.721, P < 0.05). These
changes in proteins were due to changes in their mRNAs (Figure 3), and these mRNA changes
were associated with lipid droplet content, as well. In fact, squalene reverted changes in
ACADS to values present in wild-type mice without baseline steatosis. This protein could be
a marker of hepatic steatosis. These results point out that changes in MAT1A and ACADS
levels are influenced by squalene, being the former a target of squalene administration, while
the latter is associated with its anti-steatotic properties [24].
Two genes, MAT1A and MAT2A, codify for methionine adenosyltransferases, which catalyze
the generation of S-adenosyl-L-methionine (SAMe), the main biological methyl donor. The
mammalian liver is the main organ in the regulation of serum methionine since more than
85 % of all methylation reactions and up to 48 % of methionine metabolism take place in
hepatocytes. MAT1A is the isoform present in adult liver, and mice lacking the Mat1a gene
exhibit a chronic reduction in hepatic SAMe levels and spontaneous development of nonal‐
coholic steatohepatitis [31] and hepatocellular carcinoma [32]. Recently, Mat1a deficiency has
been associated with fatty liver, by regulating phosphatidylcholine-mediated processing of
sterol regulatory element-binding protein 1 [33], required for very-low-density lipoprotein
(VLDL) assembly and plasma lipid homeostasis in mice. Therefore, the relevant role of MAT1A
in VLDL metabolism [34] may explain its increased expression in squalene-treated mice and
the significant correlation with hepatic fat content.
A family of acyl-CoA dehydrogenases, including ACADS, whose function is exerted on short-
chain acyl-CoA [35], catalyzes the initial step in fatty acid β-oxidation. A genome-wide
association study found that some variants of this gene were associated with impaired fatty
acid β-oxidation and seemed to be a marker of hepatic steatosis [36]. Thus, ACADS changes
may play a role in this condition’s amelioration induced by squalene. These findings regard‐
ing these two proteins, MAT1A and ACADS, as targets of squalene action and their role in
advanced liver diseases suggest that squalene could have a role in preventing these patholo‐
gies.
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Figure 3. Effect of squalene on hepatic Mat1a and Acads mRNA levels in male ApoE-deficient mice. (A) Hepatic mRNA
levels. Data, expressed as arbitrary absorbance units referred to Cyclophilin B gene expression obtained by RT-qPCR
analysis, are presented as mean ± SEM. Statistical analyses were carried out using the Mann-Whitney U test. **P < 0.01;
*P < 0.05. (B) Association among hepatic mRNA levels and liver fat content in ApoE-deficient mice.
6. Squalene-induced changes in microsomal proteins
Analysis of microsomal proteome showed showed that squalene induced the expression of
proteins involved in lipid (MUP8 and SCP2) and vesicular transport (NIPSNAP1 and VCP),
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protein quality control (PSMA7, PDIA3, HYOU1, and HSPA5), calcium storage (CALR), and
redox homeostasis (TXNDC5 and PYROXD2). While the role of PDIA3 in intracellular
dynamics of VLDL has been proved, this is not the case for proteins such as GRP78/HSPA5
and TXNDC5 [25]. However, TXNDC5 protein and mRNA levels showed an inverse and
statistically significant correlation with the area of lipid droplets, as reflected in Figure 4.
Figure 4. Association analyses among liver fat content and hepatic mRNA and protein levels of control and squalene-
treated Apoe-deficient mice. (A) Correlation analysis between liver fat content and protein levels, (B) correlation analy‐
sis between Txndc5 mRNA levels and liver fat content. Black squares denote chow-fed mice and gray triangles
squalene-treated mice.
TXNDC5, a member of the thioredoxin family, is considered to catalyze disulfide formation
in protein folding, to protect proteins against oxidative damage, and to prevent endoplasmic
reticulum stress [37]. A decrease in oxidative stress, evaluated as 8-isoprostaglandin F2α, was
found after squalene administration in mice [22], in agreement with other authors [38]. In this
study, the observed TXNDC5 changes could contribute to lower oxidative stress. Consider‐
ing that the latter is a factor inducing APOB degradation [39] and consequently decreases
VLDL secretion, the increase in TXNDC5 could stabilize APOB and favor VLDL secretion. This
hypothetical mechanism could explain the observed association between TXNDC5 levels and
the degree of fatty liver and represents a new role for this protein. Furthermore, the action of
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squalene was exerted at mRNA level. TXNDC5 seems to be a marker of the hepatic steatosis
developed in the absence of APOE and may play a role in this condition’s amelioration induced
by squalene. This role of TXNDC5 in terms of lipid metabolism and lipid droplets needs to be
defined.
7. A tentative model of squalene action
Overall, squalene is decreasing the hepatic content of lipids by facilitating the output of
triacylglycerols in VLDL and promoting fatty acid oxidation, as displayed in Figure 5. These
mechanisms were observed in male mice showing basal hepatic steatosis, as is the case of
apolipoprotein E deficiency.
Figure 5. Squalene action in hepatocytes of Apoe-deficient mice. Squalene decreases fatty liver extent by favoring the
secretion of VLDL and stimulating mitochondrial β-oxidation.
In addition, the complex role of dietary administered squalene is contributing to better
understand hepatic lipid dynamics. The action of squalene may help to explain the protec‐
tive role of virgin olive oil, where steatosis was observed with lower oxidative stress [40] and
lesser atherosclerosis development compared to mice receiving palm oil [41].
In acute toxicology, a no-observed-adverse-effect level (NOAEL) of 58 g/kg was detected after
a single oral dose and of 29 g/kg after intramuscular administration in mice [42]. Using 20 g/kg/
day for four days, Gajkowska et al. reported the development of encephaloneuropathy in
rats [43]. In mice, the lethal dose 50 is considered 5 g/kg/day [44], and a NOAEL of 2 g/kg/day
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was found in 10-day administration regimen [42]. The 1 g/kg/day squalene dose used in our
work is perfectly safe, and in fact, no secondary effects were noted. As mice display a higher
metabolic rate than humans [45], this dose would correspond to a human dose of 100 mg/kg/
day. Clearly, this dose is higher than the reported in human nutritional studies (15 mg/kg/
day) [46] but does not reach the doses of 185 and 385 mg/kg/day used in women [47]. Therefore,
the present study explores an attractive dose able to be reached in fortified foods and suggests
a potential squalene dose to be used as functional food or therapy in fatty liver.
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